SCHEMBL5950697

SCHEMBL5950697

CC1CSC(=S)NC1c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
HPGD P15428 3/20 0.37
CYP2D6 P10635 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
NPC1 O15118 1/20 0.36
CHRNA7 P36544 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 1/20 0.34
PKM P14618 1/20 0.34
ALOX12 P18054 1/20 0.34
RAB9A P51151 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5993375 0.74 MEN1 (0.56) ALDH1A1HPGDCYP2D6CYP1A2CYP3A4
SCHEMBL5993378 0.74 MEN1 (0.56) ALDH1A1HPGDCYP2D6CYP1A2CYP3A4
SCHEMBL17295910 0.74 MEN1 (0.56) ALDH1A1HPGDCYP2D6CYP1A2CYP3A4
Iodide SCHEMBL10779425 0.73 MEN1 (0.54) ALDH1A1HPGDCYP2D6CYP1A2CYP3A4
SCHEMBL11043486 0.67 ALDH1A1 (0.49) ALDH1A1HPGDCYP2D6CYP1A2CYP3A4
SCHEMBL21121186 0.66 SMN1; SMN2 (0.49) ALDH1A1KMT2AMEN1CHRNA7SMN1; SMN2
SCHEMBL22570459 0.66 SMN1; SMN2 (0.49) ALDH1A1KMT2AMEN1CHRNA7SMN1; SMN2
SCHEMBL21121185 0.66 SMN1; SMN2 (0.49) ALDH1A1KMT2AMEN1CHRNA7SMN1; SMN2
SCHEMBL3258947 0.64 MEN1 (0.47) ALDH1A1HPGDCYP2D6CYP1A2CYP3A4
SCHEMBL3258945 0.64 MEN1 (0.47) ALDH1A1HPGDCYP2D6CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060089352-A1 Substituted thiazines as material protecting agents LANXESS DEUTSCHLAND GMBH (DE) 2006-04-27 US claimed
US-20060089352-A1 Substituted thiazines as material protecting agents LANXESS DEUTSCHLAND GMBH (DE) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089352-A1 Substituted thiazines as material protecting agents POT1, TST, MIF ALDH1A1 431/4885HPGD 3504/4885CYP2D6 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.